Current Challenges and New Opportunities of Hybrid Nanoparticles for Diagnosis and Treatment of Cancer

Hybrid Nanoparticles (NPs) have emerged as promising tools in cancer diagnosis and treatment, offering the potential for early detection and precise eradication of malignant cells by integrating diverse materials. However, navigating this domain's intricacies, limitations, and hurdles underscores the importance of thoughtful decision-making. This editorial provides a comprehensive exploration of the merits and challenges of nanotechnology in the context of cancer diagnosis, therapy, and theranostics. It sheds light on the current applications and delves into the promising prospects in this field. This editorial aims to foster a deeper understanding of the intricacies of designing efficient protocols for hybrid NP production, contributing to advancing cancer management strategies.